Dr. Erica Linden is board certified in hematology, internal medicine, and oncology. Dr. Linden is the medical director of Breast Oncology and Cancer Genetics at Capital Health.
Dr. Linden earned her medical degree from MCP-Hahnemann School of Medicine in Philadelphia, Pennsylvania. She completed her internal medicine residency at Massachusetts General Hospital in Boston, Massachusetts. Dr. Linden was fellowship trained in hematology and medical oncology at Dana Farber Cancer Institute in Boston, Massachusetts.
Prior to joining Capital Health, Dr. Linden served as the medical oncology director of the Breast Care Program at Mass General/North Shore Cancer Center. In addition, she was a clinical affiliate in medicine in Medical Oncology/Hematology at Massachusetts General Hospital in Boston, Massachusetts. Dr. Linden was also the associate program director of the Internal Medicine Residency Program at North Shore Medical Center in Salem Massachusetts.
Throughout her career, Dr. Linden has focused on community outreach and education to various groups across the region. Her past work has focused on breast cancer risks, testing, and management with a focus on changing and novel treatments. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.